BioCentury
ARTICLE | Financial News

Kodiak raises $34M in series B

January 13, 2016 1:39 AM UTC

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) raised $34 million in a series B round led by an undisclosed U.S. investor. The company, formerly Oligasis LLC, did not respond to inquiries.

Kodiak's pipeline includes biologics KSI 201 to treat wet age-related macular degeneration (AMD) and KSI 401 for dry AMD. The company said it would use the funds to advance existing programs and add to its retinal pipeline. ...